S18-061 Small Molecule Modulators of Chimeric Antigen Receptors (CAR) T Cells Researchers at Stanford University have developed a method and composition of immunomodulatory compounds that prevent and reverse T cell exhaustion, improving on existing CAR T cell therapies. Crystal Mackall Vineet Kumar Mallesh Pandrala Evan Weber Sanjay Malhotra